Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression
Evaluating the risk of Alzheimer's disease (AD) in cognitively normal (CN) and patients with mild cognitive impairment (MCI) is extremely important. While MCI-to-AD progression risk has been studied extensively, few studies estimate CN-to-MCI conversion risk. The Cox proportional hazards (PH),...
Saved in:
Published in | Journal of Alzheimer's disease Vol. 85; no. 2; p. 837 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
01.01.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Evaluating the risk of Alzheimer's disease (AD) in cognitively normal (CN) and patients with mild cognitive impairment (MCI) is extremely important. While MCI-to-AD progression risk has been studied extensively, few studies estimate CN-to-MCI conversion risk. The Cox proportional hazards (PH), a widely used survival analysis model, assumes a linear predictor-risk relationship. Generalizing the PH model to more complex predictor-risk relationships may increase risk estimation accuracy.
The aim of this study was to develop a PH model using an Xgboost regressor, based on demographic, genetic, neuropsychiatric, and neuroimaging predictors to estimate risk of AD in patients with MCI, and the risk of MCI in CN subjects.
We replaced the Cox PH linear model with an Xgboost regressor to capture complex interactions between predictors, and non-linear predictor-risk associations. We endeavored to limit model inputs to noninvasive and more widely available predictors in order to facilitate future applicability in a wider setting.
In MCI-to-AD (n = 882), the Xgboost model achieved a concordance index (C-index) of 84.5%. When the model was used for MCI risk prediction in CN (n = 100) individuals, the C-index was 73.3%. In both applications, the C-index was statistically significantly higher in the Xgboost in comparison to the Cox PH model.
Using non-linear regressors such as Xgboost improves AD dementia risk assessment in CN and MCI. It is possible to achieve reasonable risk stratification using predictors that are relatively low-cost in terms of time, invasiveness, and availability. Future strategies for improving AD dementia risk estimation are discussed. |
---|---|
AbstractList | Evaluating the risk of Alzheimer's disease (AD) in cognitively normal (CN) and patients with mild cognitive impairment (MCI) is extremely important. While MCI-to-AD progression risk has been studied extensively, few studies estimate CN-to-MCI conversion risk. The Cox proportional hazards (PH), a widely used survival analysis model, assumes a linear predictor-risk relationship. Generalizing the PH model to more complex predictor-risk relationships may increase risk estimation accuracy.
The aim of this study was to develop a PH model using an Xgboost regressor, based on demographic, genetic, neuropsychiatric, and neuroimaging predictors to estimate risk of AD in patients with MCI, and the risk of MCI in CN subjects.
We replaced the Cox PH linear model with an Xgboost regressor to capture complex interactions between predictors, and non-linear predictor-risk associations. We endeavored to limit model inputs to noninvasive and more widely available predictors in order to facilitate future applicability in a wider setting.
In MCI-to-AD (n = 882), the Xgboost model achieved a concordance index (C-index) of 84.5%. When the model was used for MCI risk prediction in CN (n = 100) individuals, the C-index was 73.3%. In both applications, the C-index was statistically significantly higher in the Xgboost in comparison to the Cox PH model.
Using non-linear regressors such as Xgboost improves AD dementia risk assessment in CN and MCI. It is possible to achieve reasonable risk stratification using predictors that are relatively low-cost in terms of time, invasiveness, and availability. Future strategies for improving AD dementia risk estimation are discussed. |
Author | Ardekani, Babak A Moghaddam, Hamid Abrishami Lashgari, Reza Ramos-Cejudo, Jaime Khajehpiri, Boshra Forouzanfar, Mohamad Osorio, Ricardo S |
Author_xml | – sequence: 1 givenname: Boshra surname: Khajehpiri fullname: Khajehpiri, Boshra organization: Machine Vision and Medical Image Processing (MVMIP) Laboratory, Faculty of Electrical and Computer Engineering, K. N. Toosi University of Technology, Tehran, Iran – sequence: 2 givenname: Hamid Abrishami surname: Moghaddam fullname: Moghaddam, Hamid Abrishami organization: Machine Vision and Medical Image Processing (MVMIP) Laboratory, Faculty of Electrical and Computer Engineering, K. N. Toosi University of Technology, Tehran, Iran – sequence: 3 givenname: Mohamad surname: Forouzanfar fullname: Forouzanfar, Mohamad organization: Department of Systems Engineering, École deTechnologie Supérieure, Université du Québec, Montreal, Quebec, Canada – sequence: 4 givenname: Reza surname: Lashgari fullname: Lashgari, Reza organization: Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran – sequence: 5 givenname: Jaime surname: Ramos-Cejudo fullname: Ramos-Cejudo, Jaime organization: Department of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, NY, USA – sequence: 6 givenname: Ricardo S surname: Osorio fullname: Osorio, Ricardo S organization: Department of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, NY, USA – sequence: 7 givenname: Babak A surname: Ardekani fullname: Ardekani, Babak A organization: The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34864679$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkN1OAjEQRhujkR-98QFMX2C123Z3yyUiAkaUiFyTlrZYsttu2oLiM_mQLkHj1WTmm3MmmQ44tc4qAK5SdEMwIbeP_fsEpxnO8xPQTlmRJayHWAt0QtgghAjqFeegRSjLaV702uB7vvU7s-Ml7Fte7oMJ0Fg4cGtrotmpcg-fna-aeL4VG7WKAXIrDyszHo2yTf9h4jucmlL-U3BS1dz4qsnhIhi7hhzOvKudj8Y1Z-CYf3EvA5w6qcqjYfgZvaoUHHkuD2J451yIB_ZVrb0KoSEvwJnmZVCXv7ULFg_Dt8E4eXoZTQb9p2RFaBETRlmqkeJYC5qrlcgp0ZkUWFFdEKFVM0VZzhijUmdpgTXBVDAhRZFhlCmCu-D66K23olJyWXtTcb9f_r0N_wDGkHKN |
CitedBy_id | crossref_primary_10_1186_s13195_023_01268_9 crossref_primary_10_3389_fams_2023_1195810 crossref_primary_10_1109_ACCESS_2023_3344319 crossref_primary_10_12677_ACM_2023_13112547 crossref_primary_10_1016_j_isci_2023_107522 crossref_primary_10_1371_journal_pone_0314725 crossref_primary_10_1038_s41598_024_51402_2 |
ContentType | Journal Article |
CorporateAuthor | Alzheimer’s Disease Neuroimaging Initiative |
CorporateAuthor_xml | – name: Alzheimer’s Disease Neuroimaging Initiative |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.3233/JAD-215266 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1875-8908 |
ExternalDocumentID | 34864679 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: CIHR – fundername: NIA NIH HHS grantid: U01 AG024904 |
GroupedDBID | --- 0R~ 0VX 29J 36B 4.4 53G 5GY AAFNC AAWTL ABDBF ABIVO ABJNI ABUBZ ABUJY ACGFS ACPQW ACPRK ACUHS ADZMO AELRD AENEX AFRAH AFRHK AGIAB AHDMH AIRSE AJNRN ALMA_UNASSIGNED_HOLDINGS CAG CGR COF CUY CVF DU5 EAD EAP EBS ECM EIF EJD EMB EMK EMOBN ESX F5P HZ~ IL9 IOS MET MIO MV1 NGNOM NPM O9- P2P Q1R S70 SV3 TUS VUG |
ID | FETCH-LOGICAL-c347t-8481f0ea2fb46ecb643f5db2e4f73bfeb460568884df5172f324b8bdb75205e32 |
IngestDate | Thu Apr 03 07:06:43 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | magnetic resonance imaging Alzheimer’s disease Xgboost survival analysis proportional hazards model mild cognitive impairment hippocampal atrophy brain machine learning |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c347t-8481f0ea2fb46ecb643f5db2e4f73bfeb460568884df5172f324b8bdb75205e32 |
PMID | 34864679 |
ParticipantIDs | pubmed_primary_34864679 |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of Alzheimer's disease |
PublicationTitleAlternate | J Alzheimers Dis |
PublicationYear | 2022 |
SSID | ssj0003097 |
Score | 2.3926294 |
Snippet | Evaluating the risk of Alzheimer's disease (AD) in cognitively normal (CN) and patients with mild cognitive impairment (MCI) is extremely important. While... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 837 |
SubjectTerms | Aged Aged, 80 and over Alzheimer Disease - diagnosis Alzheimer Disease - epidemiology Alzheimer Disease - genetics Cognitive Dysfunction - diagnosis Cognitive Dysfunction - epidemiology Cognitive Dysfunction - genetics Disease Progression Female Genetic Testing - methods Humans Magnetic Resonance Imaging Male Neuropsychological Tests Prognosis Proportional Hazards Models Risk Assessment - methods Survival Analysis |
Title | Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34864679 |
Volume | 85 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFICtDiS0FwTifpMfeJsCrePcHgtsVIPyAJu0t8l27CZTm1ZtOo38Jv4Y_4Jz7HiJKiYuL1EUx1Hk89k-ts-FkNe4mz8SKfRvxUXAtYI-Z7IwMIlWo5wJkcbo4Dz9Ek9O-fFZdDYY_OxZLW1r-UY1v_Ur-R-pwjOQK3rJ_oNkrz8KD-Ae5AtXkDBc_0rG37bQ0S-xkX1oEevD1xoEzb_jqcwCw31s5YW12nChljAuf9l5tk3Led7VwnjBolxbGwFnTyDQmwDV9DYUsWjQUctmUWtN3A-vatxmPPi4tgZkNXpQbGpn2DdzhrbVTVrwvCl0aVO4JJvd46JPhbjQxap03vDvlptifT2LTJezAkZNx_NELMr8YIzeCwXcdlPrerltRGWcFfl0CYUi96WfxaaYCfftr7oR_Q0QxnobINoN2rDmCtJsmPZHdZcIqKWX9Ybo1AWZ2Z06QoZb20fH4w8Bpvp1qWB6DK0WFqKQpzHMLdmfS3fCePuiPbIHCxrM0IrbSq3KEA6zxMXOxd942_3EPrnjK-6se6z-c3KP3G1FRseOwvtkoKsH5IcnkHoCaVnRHoHUEUg9gRQIxFc8gRT5oUhgV4t2BFJLIBW0TyBtCaSWQPeFlkDqCaSeQNoR-JCcHh2evJ8Ebf6PQIU8qQPM9GCGWjAjeayVBOXZRLlkmpsklEZLPNOP0zTluYlAETewOJCpzGUSsWGkQ_aI3KqWlX5CqGZKMRh6DCzAeZRlIpS5iZVUuVLcjEZPyWPXuOcrF-Tl3Df7sxtLnpP9DscX5LaBUUW_BBW1lq-seH8BF8ud4g |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survival+Analysis+in+Cognitively+Normal+Subjects+and+in+Patients+with+Mild+Cognitive+Impairment+Using+a+Proportional+Hazards+Model+with+Extreme+Gradient+Boosting+Regression&rft.jtitle=Journal+of+Alzheimer%27s+disease&rft.au=Khajehpiri%2C+Boshra&rft.au=Moghaddam%2C+Hamid+Abrishami&rft.au=Forouzanfar%2C+Mohamad&rft.au=Lashgari%2C+Reza&rft.date=2022-01-01&rft.eissn=1875-8908&rft.volume=85&rft.issue=2&rft.spage=837&rft_id=info:doi/10.3233%2FJAD-215266&rft_id=info%3Apmid%2F34864679&rft_id=info%3Apmid%2F34864679&rft.externalDocID=34864679 |